VALN earnings: next report 2026-08-11, real EPS beat/miss history, analyst consensus Buy, P/E -2.64. Updated 2026-07-23.
Valneva (VALN) Research Hub
Valneva (VALN) trades on NASDAQ, FR in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 6.66 USD (-0.30%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -2.64, market cap 0.47B. This hub links to the full technical, earnings and options research available for VALN.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, FR |
| Last close | 6.66 USD (-0.30%) |
| 52-week range | 4.75 USD – 7.3 USD |
| Trend regime | Range |
| 14-day RSI | 68.6 (Bullish) |
| Trailing P/E | -2.64 |
| Market cap | 0.47B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-11 |
Available research for VALN
Covered Call on VALN: how it works, illustrative setup around the real 6.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on VALN: how it works, illustrative setup around the real 6.66 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on VALN: how it works, illustrative setup around the real 6.66 USD price, max profit/loss, breakeven and when to use it. Educational.
VALN technical analysis: range, last 6.66 USD, RSI 68.6, 52w range 4.75 USD–7.3 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is VALN in?
Valneva (VALN) is classified under Healthcare (Biotechnology), listed on NASDAQ, FR.
Is VALN in an uptrend or downtrend?
As of 2026-09-11, VALN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is VALN's trailing P/E ratio?
VALN's trailing P/E is -2.64, with a market cap of 0.47B. See the earnings research page for full valuation detail.
When does VALN next report earnings?
VALN is next scheduled to report earnings on 2026-08-11, with a consensus EPS estimate of -0.18872 USD.